Key Takeaways
- • Eurex launched Systematic Quantitative Investment Strategies (QIS) Index Futures on 1 December 2025, expanding its "futurization" strategy to convert over-the-counter products into listed, centrally cleared derivatives.
- • The QIS index futures are developed in partnership with Premialab and offer three initial contracts providing exposure to thematic and factor-based strategies (macro, AI, value) using mathematical models that blend active and passive investment approaches.
- • QIS index futures provide cross-margining potential and standardized clearing as an alternative to bespoke OTC swaps, addressing institutional demand for customized products with improved capital and operational efficiency.
- • The launch was delayed from its originally announced October 2025 date due to the U.S. government shutdown and disruptions to CFTC operations; confirmation came via memo on 27 November 2025.
- • Eurex's futurization strategy has demonstrated traction, with total return futures (TRFs)—launched in 2016—showing significant year-over-year volume growth, validating the exchange's approach to migrating OTC products to listed venues.
Summary
Deutsche Börse Group's Eurex derivatives business formally launched Systematic QIS Index Futures on 1 December 2025, marking the latest iteration of its multi-year "futurization" initiative. The strategy centers on converting over-the-counter derivative products into listed, centrally cleared contracts—a structural shift designed to enhance capital efficiency, operational resilience, and market access for institutional participants. The launch was confirmed via official memo on 27 November 2025, following an earlier announcement that had been delayed due to U.S. government shutdown impacts on CFTC operations.
The QIS index futures represent the next generation of customizable index derivatives. Developed in partnership with Premialab, a specialized data and analytics provider focused on quantitative investment strategies, the contracts initially comprise three index futures offerings. These products address a stated priority outlined by Robbert Booij, Eurex's chief executive: meeting client demand for bespoke products while maintaining standardized market infrastructure. QIS indices employ mathematical models that combine active and passive investment techniques, allowing market participants to gain targeted exposure to or hedge against identified macro and factor-based themes—including AI and value strategies—through a listed, standardized framework rather than bilateral OTC arrangements.
From a structural perspective, the new contracts function as a futurized alternative to proprietary index swaps. They offer standardized pricing, centralized clearing through Eurex Clearing AG, and cross-margining capability—operational advantages that reduce counterparty risk and capital requirements compared to bilateral OTC derivatives. The contracts maintain rules-based indices while providing the transparency and efficiency benefits of exchange-listed trading.
Eurex's futurization approach has already demonstrated market validation. Total return futures (TRFs), which enable investors to capture full index returns without purchasing underlying constituents, were introduced in 2016 and have achieved significant year-over-year volume growth—evidence that institutional investors are receptive to migrating from OTC to listed, cleared structures when products offer equivalent economic exposure with superior operational characteristics. The QIS index futures launch extends this framework to systematically managed strategies, broadening Eurex's appeal to quantitative and factor-focused asset managers.
The QIS index futures represent the next generation of customizable index derivatives. Developed in partnership with Premialab, a specialized data and analytics provider focused on quantitative investment strategies, the contracts initially comprise three index futures offerings. These products address a stated priority outlined by Robbert Booij, Eurex's chief executive: meeting client demand for bespoke products while maintaining standardized market infrastructure. QIS indices employ mathematical models that combine active and passive investment techniques, allowing market participants to gain targeted exposure to or hedge against identified macro and factor-based themes—including AI and value strategies—through a listed, standardized framework rather than bilateral OTC arrangements.
From a structural perspective, the new contracts function as a futurized alternative to proprietary index swaps. They offer standardized pricing, centralized clearing through Eurex Clearing AG, and cross-margining capability—operational advantages that reduce counterparty risk and capital requirements compared to bilateral OTC derivatives. The contracts maintain rules-based indices while providing the transparency and efficiency benefits of exchange-listed trading.
Eurex's futurization approach has already demonstrated market validation. Total return futures (TRFs), which enable investors to capture full index returns without purchasing underlying constituents, were introduced in 2016 and have achieved significant year-over-year volume growth—evidence that institutional investors are receptive to migrating from OTC to listed, cleared structures when products offer equivalent economic exposure with superior operational characteristics. The QIS index futures launch extends this framework to systematically managed strategies, broadening Eurex's appeal to quantitative and factor-focused asset managers.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.